High expression of METTL14 was reported to be significantly correlated with low overall survival of patients with NB, and the high-risk group was highly enriched in MYC targets, suggesting that METTL14 exerted its potential functions through MYC-associated pathways. This evidence concerns the gene METTL14 and neuroblastoma.